Literature DB >> 23474441

Transcriptional cooperation between p53 and NF-κB p65 regulates microRNA-224 transcription in mouse ovarian granulosa cells.

Meng Liang1, Guidong Yao, Mianmian Yin, Mingrong Lü, Hui Tian, Lin Liu, Jie Lian, Xingxu Huang, Fei Sun.   

Abstract

MicroRNAs (miRNAs) have been indicated to play key roles in ovarian follicular development. However, little is known about how the miRNA gene expression itself is regulated in the mammalian ovary. We previously reported that miR-224 is involved in TGF-β1-mediated follicular granulosa cell (GC) growth and estradiol (E2) production by targeting Smad4. Here, the transcriptional regulation of miR-224 expression in GCs was further investigated. Our results showed that both the tumor suppressor gene p53 and NF-κB p65 subunit suppressed the TGF-β1-induced increase in pri-miR-224 expression in GCs. ChIP assays demonstrated that TGF-β1 enhanced the binding of p53 and p65 to the proximal promoter region of GABAA receptor ε subunit (miR-224 host gene). p53 and p65 transcriptionally cooperated to inactivate the GABAA receptor ε subunit promoter. In addition, p53/p65 could up-regulate Smad4 expression by inhibiting its target miR-224 in GCs which contributed, at least partially, to the effects of miR-224 and Smad4 on GC proliferation and E2 release. Our results provide new data about the interplay between transcription factors involved in GC proliferation and function by cooperatively regulating miRNA expression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474441     DOI: 10.1016/j.mce.2013.02.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  34 in total

1.  The MicroRNA-224 Inhibitor Prevents Neuronal Apoptosis via Targeting Spastic Paraplegia 7 After Cerebral Ischemia.

Authors:  Feng Fu; Dingfeng Wu; Chao Qian
Journal:  J Mol Neurosci       Date:  2016-05-10       Impact factor: 3.444

Review 2.  MicroRNA in Ovarian Biology and Disease.

Authors:  Lynda K McGinnis; Lacey J Luense; Lane K Christenson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

3.  MicroRNAs control transcription factor NF-kB (p65) expression in human ovarian cells.

Authors:  Alexander V Sirotkin; Richard Alexa; Gabriela Kišová; Abdel Halim Harrath; Saleh Alwasel; Dmitriy Ovcharenko; Miloš Mlynček
Journal:  Funct Integr Genomics       Date:  2014-11-18       Impact factor: 3.410

4.  Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.

Authors:  Jayeeta Ghose; N P Bhattacharyya
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 5.  Exploiting microRNAs As Cancer Therapeutics.

Authors:  Tamsin Robb; Glen Reid; Cherie Blenkiron
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

6.  [Medium-chain acyl-CoA dehydrogenase enhances invasion and metastasis ability of breast cancer cells].

Authors:  Yinjue Yu; Linfeng Zhao; Rong Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

7.  Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.

Authors:  Ke Hu; Meng Liang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-23       Impact factor: 2.416

Review 8.  Non-coding RNA in Ovarian Development and Disease.

Authors:  J Browning Fitzgerald; Jitu George; Lane K Christenson
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 9.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

Review 10.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.